Pague Menos (PGMN3), one of the largest pharmaceutical retail chains in Brazil, reported adjusted net income growth of 22.2% year-over-year to R$ 73.6 million for the second quarter of 2026, fueled by a record high in operating profitability. The company’s Adjusted EBITDA margin reached an all-time high of 6.5%, up from 6.1% in the same quarter last year, marking a decisive shift toward structural profitability despite a recent slowdown in top-line growth.